Special Issue "Macular Edema: Pathogenesis, Diagnosis and Therapies"
Deadline for manuscript submissions: closed (10 November 2023) | Viewed by 12228
Interests: retinal vein occlusion; macular edema; cytokines; diabetic retinopathy (macular edema, cytokines in humans, macular circulation in humans)
Macular edema is one of the leading causes of visual impairment and blindness worldwide. Typical diseases that cause macular edema are diabetic retinopathy and retinal vein occlusion. Recently, the pathogenesis of macular edema has been investigated by clinical and basic studies using advanced imaging analyses (e.g., optical coherence tomography angiography) and analyses of molecular biology (e.g., discovery of vascular endothelial growth factor). As a result, the diagnostic methods for macular edema have been facilitated. Furthermore, anti-VEGF agents and other new drugs under development and newly proposed surgical techniques will change the treatment method and regimen for macular edema.
Based on the background, I am organizing a Special Issue entitled “Macular Edema: Pathogenesis, Diagnosis and Therapies” in the journal Medicina. Briefly, I aim to collect clinical research including interventional or observational studies which will stimulate the basic researchers to find topics for future research. You can submit both original works and reviews.
Dr. Hidetaka Noma
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- macular edema
- diabetic retinopathy
- retinal vein occlusion
- anti-VEGF therapy
- retinal photocoagulation
- treatment strategy